[HTML][HTML] Incorporation of Ebola glycoprotein into HIV particles facilitates dendritic cell and macrophage targeting and enhances HIV-specific immune responses

Z Ao, L Wang, EJ Mendoza, K Cheng, W Zhu… - PloS one, 2019 - journals.plos.org
The development of an effective vaccine against HIV infection remains a global priority.
Dendritic cell (DC)-based HIV immunotherapeutic vaccine is a promising approach which …

[PDF][PDF] Incorporation of Ebola glycoprotein into HIV particles facilitates dendritic cell and macrophage targeting and enhances HIV-specific immune responses

Z Ao, L Wang, EJ Mendoza, K Cheng, W Zhu… - PLoS …, 2019 - pdfs.semanticscholar.org
The development of an effective vaccine against HIV infection remains a global priority.
Dendritic cell (DC)-based HIV immunotherapeutic vaccine is a promising approach which …

Incorporation of Ebola glycoprotein into HIV particles facilitates dendritic cell and macrophage targeting and enhances HIV-specific immune responses

Z Ao, L Wang, EJ Mendoza, K Cheng, W Zhu… - PloS …, 2019 - researchexperts.utmb.edu
The development of an effective vaccine against HIV infection remains a global priority.
Dendritic cell (DC)-based HIV immunotherapeutic vaccine is a promising approach which …

Incorporation of Ebola glycoprotein into HIV particles facilitates dendritic cell and macrophage targeting and enhances HIV-specific immune responses

Z Ao, L Wang, EJ Mendoza, K Cheng, W Zhu… - PLoS ONE, 2019 - go.gale.com
The development of an effective vaccine against HIV infection remains a global priority.
Dendritic cell (DC)-based HIV immunotherapeutic vaccine is a promising approach which …

[HTML][HTML] Incorporation of Ebola glycoprotein into HIV particles facilitates dendritic cell and macrophage targeting and enhances HIV-specific immune responses

Z Ao, L Wang, EJ Mendoza, K Cheng, W Zhu… - PLoS ONE, 2019 - ncbi.nlm.nih.gov
The development of an effective vaccine against HIV infection remains a global priority.
Dendritic cell (DC)-based HIV immunotherapeutic vaccine is a promising approach which …

Incorporation of Ebola glycoprotein into HIV particles facilitates dendritic cell and macrophage targeting and enhances HIV-specific immune responses

Z Ao, L Wang, EJ Mendoza, K Cheng, W Zhu… - PloS …, 2019 - pubmed.ncbi.nlm.nih.gov
The development of an effective vaccine against HIV infection remains a global priority.
Dendritic cell (DC)-based HIV immunotherapeutic vaccine is a promising approach which …

Incorporation of Ebola glycoprotein into HIV particles facilitates dendritic cell and macrophage targeting and enhances HIV-specific immune responses.

Z Ao, L Wang, EJ Mendoza, K Cheng, W Zhu… - Plos one, 2019 - europepmc.org
The development of an effective vaccine against HIV infection remains a global priority.
Dendritic cell (DC)-based HIV immunotherapeutic vaccine is a promising approach which …

Incorporation of Ebola glycoprotein into HIV particles facilitates dendritic cell and macrophage targeting and enhances HIV-specific immune responses.

Z Ao, L Wang, EJ Mendoza, K Cheng, W Zhu… - PLoS …, 2019 - search.ebscohost.com
The development of an effective vaccine against HIV infection remains a global priority.
Dendritic cell (DC)-based HIV immunotherapeutic vaccine is a promising approach which …

[PDF][PDF] Incorporation of Ebola glycoprotein into HIV particles facilitates dendritic cell and macrophage targeting and enhances HIV-specific immune responses

Z Ao, L Wang, EJ Mendoza, K Cheng, W Zhu… - PLoS ONE, 2019 - academia.edu
The development of an effective vaccine against HIV infection remains a global priority.
Dendritic cell (DC)-based HIV immunotherapeutic vaccine is a promising approach which …

[引用][C] Incorporation of Ebola glycoprotein into HIV particles facilitates dendritic cell and macrophage targeting and enhances HIV-specific immune responses

Z Ao, L Wang, EJ Mendoza, K Cheng, W Zhu… - PLoS …, 2019 - ui.adsabs.harvard.edu
Incorporation of Ebola glycoprotein into HIV particles facilitates dendritic cell and macrophage
targeting and enhances HIV-specific immune responses - NASA/ADS Now on home page ads …